Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Klinkhardt

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Clinical Pharmacology and Therapeutics|March 31, 2000
Ex vivo--in vitro interaction between aspirin, clopidogrel, and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566AU Klinkhardt, C M Kirchmaier, D Westrup, et al.
British Journal of Clinical Pharmacology|June 26, 2001
Platelet CD62 expression and PDGFAB secretion in patients undergoing PTCA and treatment with abciximabJ Graff, D Andries, M Elsner, et al.
Kidney International|June 26, 2001
Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathwayJ Gossmann, R Burkhardt, S Harder, et al.
British Journal of Clinical Pharmacology|September 19, 2001
Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjectsU Klinkhardt, J Graff, D Westrup, et al.
Journal of Thrombosis and Haemostasis : JTH|October 6, 2007
Effects of selective COX-2 inhibition on prostanoids and platelet physiology in young healthy volunteersJ Graff, C Skarke, U Klinkhardt, et al.
Thrombosis Research|February 16, 2000
Differential in vitro effects of the platelet glycoprotein IIb/IIIa inhibitors abixicimab or SR121566A on platelet aggregation, fibrinogen binding and platelet secretory parametersU Klinkhardt, C M Kirchmaier, D Westrup, et al.
Clinical Pharmacology and Therapeutics|December 5, 2000
Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: a placebo-controlled study in healthy volunteersJ Gossmann, R Burkhardt, S Harder, et al.
European Journal of Cancer (Oxford, England : 1990)|May 5, 2015
FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancerC Bokemeyer, C-H Köhne, F Ciardiello, et al.
Thrombosis Research|April 27, 2001
In vitro dose response to different GPIIb/IIIa-antagonists: inter-laboratory comparison of various platelet function testsS Harder, U Klinkhardt, J Graff, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Pharmacology and Therapeutics|March 31, 2000
Ex vivo--in vitro interaction between aspirin, clopidogrel, and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566AU Klinkhardt, C M Kirchmaier, D Westrup, et al.
British Journal of Clinical Pharmacology|June 26, 2001
Platelet CD62 expression and PDGFAB secretion in patients undergoing PTCA and treatment with abciximabJ Graff, D Andries, M Elsner, et al.
Kidney International|June 26, 2001
Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathwayJ Gossmann, R Burkhardt, S Harder, et al.
British Journal of Clinical Pharmacology|September 19, 2001
Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjectsU Klinkhardt, J Graff, D Westrup, et al.
Journal of Thrombosis and Haemostasis : JTH|October 6, 2007
Effects of selective COX-2 inhibition on prostanoids and platelet physiology in young healthy volunteersJ Graff, C Skarke, U Klinkhardt, et al.
Thrombosis Research|February 16, 2000
Differential in vitro effects of the platelet glycoprotein IIb/IIIa inhibitors abixicimab or SR121566A on platelet aggregation, fibrinogen binding and platelet secretory parametersU Klinkhardt, C M Kirchmaier, D Westrup, et al.
Clinical Pharmacology and Therapeutics|December 5, 2000
Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: a placebo-controlled study in healthy volunteersJ Gossmann, R Burkhardt, S Harder, et al.
European Journal of Cancer (Oxford, England : 1990)|May 5, 2015
FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancerC Bokemeyer, C-H Köhne, F Ciardiello, et al.
Thrombosis Research|April 27, 2001
In vitro dose response to different GPIIb/IIIa-antagonists: inter-laboratory comparison of various platelet function testsS Harder, U Klinkhardt, J Graff, et al.
Pageof 2